chr4-139351510-A-C
Variant names: 
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_057175.5(NAA15):c.913A>C(p.Lys305Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000000703 in 1,423,298 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: not found (cov: 32) 
 Exomes 𝑓:  7.0e-7   (  0   hom.  ) 
Consequence
 NAA15
NM_057175.5 missense
NM_057175.5 missense
Scores
 1
 5
 13
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  6.93  
Publications
0 publications found 
Genes affected
 NAA15  (HGNC:30782):  (N-alpha-acetyltransferase 15, NatA auxiliary subunit) N-alpha-acetylation is among the most common post-translational protein modifications in eukaryotic cells. This process involves the transfer of an acetyl group from acetyl-coenzyme A to the alpha-amino group on a nascent polypeptide and is essential for normal cell function. This gene encodes the auxillary subunit of the N-terminal acetyltransferase A (NatA) complex. [provided by RefSeq, Jan 2017] 
NAA15 Gene-Disease associations (from GenCC):
- intellectual disability, autosomal dominant 50Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Illumina, Labcorp Genetics (formerly Invitae)
- syndromic intellectual disabilityInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD3 genomes 
Cov.: 
32
GnomAD4 exome  AF:  7.03e-7  AC: 1AN: 1423298Hom.:  0  Cov.: 25 AF XY:  0.00  AC XY: 0AN XY: 710436 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
1
AN: 
1423298
Hom.: 
Cov.: 
25
 AF XY: 
AC XY: 
0
AN XY: 
710436
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
32638
American (AMR) 
 AF: 
AC: 
0
AN: 
44180
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
25790
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39458
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
84664
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53364
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5696
European-Non Finnish (NFE) 
 AF: 
AC: 
1
AN: 
1078500
Other (OTH) 
 AF: 
AC: 
0
AN: 
59008
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.525 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  
GnomAD4 genome 
Cov.: 
32
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Benign 
 BayesDel_addAF 
 Benign 
T 
 BayesDel_noAF 
 Benign 
 DANN 
 Uncertain 
 DEOGEN2 
 Benign 
T;. 
 Eigen 
 Benign 
 Eigen_PC 
 Uncertain 
 FATHMM_MKL 
 Pathogenic 
D 
 LIST_S2 
 Uncertain 
D;D 
 M_CAP 
 Benign 
T 
 MetaRNN 
 Benign 
T;T 
 MetaSVM 
 Benign 
T 
 MutationAssessor 
 Uncertain 
M;. 
 PhyloP100 
 PrimateAI 
 Uncertain 
T 
 PROVEAN 
 Benign 
N;N 
 REVEL 
 Benign 
 Sift 
 Benign 
T;T 
 Sift4G 
 Benign 
T;T 
 Polyphen 
B;. 
 Vest4 
 MutPred 
Loss of ubiquitination at K305 (P = 0.0381);Loss of ubiquitination at K305 (P = 0.0381);
 MVP 
 MPC 
 ClinPred 
D 
 GERP RS 
 Varity_R 
 gMVP 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 DS_AG_spliceai 
Position offset: 3
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.